Abstract
The receptor for EGF is an integral membrane protein that mediates the mitogenic response of target cells to EGF and EGF-like polypeptides (1). The EGF receptor has been purified from cultured human tumor cells (2,3) and mouse liver (4). The receptor is a glycoprotein having an estimated molecular mass of approximately 170,000 daltons and no subunit structure. In addition to the N-linked oligosaccharide chains, the EGF receptor is also modified post-translationally by phosphate on serine, threonine, and tyrosine residues and extensive disulfide bond arrangement is predicted. In addition to the molecule’s ligand binding capacity, the receptor acts as an allosteric enzyme; it contains a tyrosine-specific protein kinase activity that is activated by the binding of EGF (5,6). However, substrates of this receptor-kinase that are physiologically relevant to mito-genesis have not yet been identified. The focus of this article will be on the glycosylation of the EGF receptor during the biosynthesis of this molecule.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
G. Carpenter, The receptors for epidermal growth factor and other polypeptide mitogens, Ann. Rev. Biochem. 56:881 (1987).
S. Cohen, G. Carpenter and L. King, Jr., Epidermal growth factor (EGF)-receptor-protein kinase interactions: co-purification of receptor and EGF-enhanced phosphorylation activity, J. Biol. Chem. 255:4834 (1980).
S. Cohen, H. Ushiro, C. Stoscheck and M. Chinkers, A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles, J. Biol. Chem. 257:1523 (1982).
S. Cohen, R.A. Fava, and S.T. Sawyer, Purification and characterization of epidermal growth factor receptor/protein kinase from normal mouse liver, Proc. Natl. Acad. Sci. USA 79:6237 (1982).
G. Carpenter, L. King, and S. Cohen, Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor, J. Biol. Chem. 254:4884 (1979).
H. Ushiro, and S. Cohen, Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes, J. Biol. Chem. 255:8363 (1980).
H. Haigler, J.F. Ash, S. J. Singer, and S. Cohen, Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431, Proc. Natl. Acad. Sci. USA 75:3317 (1978).
C.M. Stoscheck, and G. Carpenter, Biology of the A-431 cell: a useful organism for hormone research, J. Cell. Biochem. 23:191 (1983).
D.J. Giard, S.A. Aaronson, G.J. Todaro, P. Aronstein, and J.H. Kersey, et al., In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors, J. Natl. Cancer Inst. 51:1417 (1973).
M. Das, T. Miyakawa, CF. Fox, R.M. Pruss, A. Aharonov, and H.R. Herschman, Specific radiolabeling of a cell surface receptor for epidermal growth factor, Proc. Natl. Acad. Sci. USA 74:2790 (1977).
M.M. Wrann, and CF. Fox, Identification of epidermal growth factor receptors in a hyperproducing human epidermoid carcinoma cell line, J. Biol. Chem. 254:8083 (1979).
R.A. Hock, E. Nexø, and M.D. Hollenberg, Isolation of the human placenta receptor for epidermal growth factor — urogastrone, Nature 277:403 (1979).
D. Cassei, and L. Glaser, Proteolytic cleavage of epidermal growth factor receptor, J. Biol. Chem. 257:9845 (1982).
R.E. Gates, and L.E. King, Jr., Calcium facilitates endogenous proteolysis of the EGF receptor-kinase, Mol. Cell. Endocrinol. 27:263 (1982).
R.A. Hock, E. Nexø, and M.D. Hollenberg, Solubilization and isolation of the human placenta receptor for epidermal growth factor — urogastrone, J. Biol. Chem. 255:10737 (1980).
L.J. Pike, E.A. Kuenzel, J.E. Casnellie, and E.G. Krebs, A comparison of the insulin- and epidermal growth factor-stimulated protein kinases from human placenta, J. Biol. Chem. 259:9913 (1984).
G. Carpenter, L. King, Jr., and S. Cohen, Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro, Nature 276:409 (1978).
S.A. Buhrow, S. Cohen, and J.V. Staros, Affinity labeling of the protein kinase associated with the epidermal growth factor receptor in membrane vesicles from A431 cells, J. Biol. Chem. 257:4019 (1982).
S.A. Buhrow, S. Cohen, D.L. Garbers, and J.V. Staros, Characterization of the interaction of 5’-p-fluorosulfonyl benzoyl adenosine with the epidermal growth factor receptor/protein kinase in A431 cell membranes, J. Biol. Chem. 258:7824 (1983).
J. Downward, Y. Yarden, E. Mayes, G. Scrace, and N. Totty, et al., Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences, Nature 307:521 (1984).
A. Ullrich, L. Coussens, J.S. Hayflick, T.J. Dull, and A. Gray, et al., Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells, Nature 309:418 (1984).
E.L.V. Mayes, and M.D. Waterfield, Biosynthesis of the epidermal growth factor receptor in A431 cells, EMB0 J. 3:531 (1984).
A.M. Soderquist, and G. Carpenter, Glycosylation of the epidermal growth factor receptor in A-431 cells: the contribution of carbohydrate to receptor function, J. Biol. Chem. 259:12586 (1984).
S.J. Decker, Aspects of the metabolism of the epidermal growth factor receptor in A431 human epidermoid carcinoma cells, Mol. Cell. Biol. 4:571 (1984).
M.W. Russo, C.A. Guyer, A. Goldman, and J.V. Staros, A model for the EGF receptor/kinase containing multiple transmembrane α-helices, Biophys. J. 51:36a (1986).
R.D. Cummings, A.M. Soderquist, and G. Carpenter, The oligosaccharide moieties of the epidermal growth factor receptor in A-431 cells: presence of both high-mannose N-linked chains and complex chains that contain N-acetylgalactosamine residues, J. Biol. Chem. 260:11944 (1985).
R.A. Childs, M. Gregoriou, P. Scudder, S.J. Thorpe, and A.R. Rees, et al., Blood group active carbohydrate chains on the receptor for epidermal growth factor of A431 cells, EMB0 J. 3:2227 (1984).
L. Pollack, and P.H. Atkinson, Correlation of glycosylation forms with position in amino acid sequence, J. Cell Biol. 97:293 (1983).
H.C. Gooi, E.F. Hounsell, J.K. Picard, A.D. Lowe, and D. Voak, et al., Differing reactions of monoclonal anti-A antibodies with oligosaccharides related to blood group A, J. Biol. Chem. 260:13218 (1985).
H.C. Gooi, J.K. Picard, E.F. Hounsell, M. Gregoriou, and A.R. Rees, et al., Monoclonal antibody (EGR/G49) reactive with the epidermal growth factor receptor of A431 cells recognizes the blood group ALeb and Aley structures, Mol. Immunol. 22:689 (1985).
H.C. Gooi, E.F. Hounsell, I. Lax, R.M. Kris, and T.A. Libermann, et al., The carbohydrate specificities of the monoclonal antibodies 29.1, 455 and 3C1B12 to the epidermal growth factor receptor of A431 cells, Biosci. Rep. 5:83 (1985).
P. Fredman, N.D. Richert, J.L. Magnani, M.C. Willingham, and I. Pastan, A monoclonal antibody that precipitates the glycoprotein receptor for epidermal growth factor is directed against the human blood group H type 1 antigen, J. Biol. Chem. 258:11206 (1983).
R.W. Yeaton, M.T. Lipari, and C.F. Fox, Calcium-mediated degradation of epidermal growth factor receptor in dislodged A431 cells and membrane preparations, J. Biol. Chem. 258:9254 (1983).
M. Chinkers, and J.S. Brugge, Characterization of structural domains of the human epidermal growth factor receptor obtained by partial proteolysis, J. Biol. Chem. 259:11534 (1984).
M. Chinkers, and D. Garbers, Phorbol ester-induced threonine phosphorylation of the human epidermal growth factor receptor occurs within the EGF binding domain, Biochem. Biophys. Res. Commun. 123:618 (1984).
T. Hunter, N. Ling, and J.A. Cooper, Protein kinase c phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane, Nature 311:480 (1984).
R.J. Davis, and M.P. Czech, Tumor-promoting phorbol diesters cause the phosphorylation of epidermal growth factor receptors in normal human fibroblasts at threonine-654, Proc. Natl. Acad. Sci. USA 82:1974 (1985).
M.W. Russo, T.J. Lukas, S. Cohen, and J.V. Staros, Identification of residues in the nucleotide binding site of the epidermal growth factor receptor/kinase, J. Biol. Chem. 260:5205 (1985).
J. Downward, P. Parker, and M.D. Waterfield, Autophosphorylation sites on the epidermal growth factor receptor, Nature 311:483 (1984).
T. Hunter, and J.A. Cooper, Protein-tyrosine kinases, Ann. Rev. Biochem. 54:897 (1985).
J.G. Foulkes, and M.R. Rosner, Tyrosine-specific protein kinases as mediators of growth control, in: “Molecular Mechanisms of Transmembrane Signalling,” P. Cohen, and M.D. Houslay, ed., p. 217, Amsterdam/New York: Elsevier (1985).
J.V. Staros, S. Cohen, and M.W. Russo, Epidermal growth factor receptors: characterization of its protein kinase activity, see Ref. 41, pp. 253 (1985).
B. Gallis, A. Lewis, J. Wignall, A. Alpert, and D.Y. Mochizuki, et al., Phosphorylation of the human interleukin-2 receptor and a synthetic peptide identical to its c-terminal, cytoplasmic domain, J. Biol. Chem. 261:5075 (1986).
D.A. Shackelford, and I.S. Trowbridge, Identification of lymphocyte integral membrane proteins as substrates for protein kinase c, J. Biol. Chem. 261:8334 (1986).
G. Weinmaster, M.J. Zoller, and T. Pawson, A lysine in the ATP-binding site of P130 gag-fps is essential for protein-tyrosine kinase activity, EMBO J. 5:69 (1986).
J. Downward, M.D. Waterfield, and P. Parker, Autophosphorylation and protein kinase c phosphorylation of the epidermal growth factor receptor, J. Biol. Chem. 260:14538 (1985).
R.E. Gates, and L.E. King, Jr., Different forms of the epidermal growth factor receptor kinase have different autophosphorylation sites, Biochemistry 24:5209 (1985).
W.J. Gullick, J. Downward, and M.D. Waterfield, Antibodies to the autophosphorylation sites of the epidermal growth receptor protein-tyrosine kinase as probes of structure and function, EMBO J. 4:2869 (1985).
C. Erneaux, S. Cohen, and G.L. Garbers, The kinetics of tyrosine phosphorylation by the purified epidermal growth factor receptor kinase of A431 cells, J. Biol. Chem. 258:4137 (1985).
L.E. King, Jr., and R.E. Gates, Calcium-activated neutral protease purified from beef lung: properties and use in defining structure of epidermal growth factor receptors, Arch. Biochem. Biophys. 242:146 (1985).
T. Sasaki, T. Kikuchi, N. Yumoto, N. Yoshimura, and T. Murachi, Comparative specificity and kinetic studies on porcine calpain I and calpain II with naturally occurring peptides and synthetic fluorogenic substrates, J. Biol. Chem. 259:12489 (1984).
B. Ek, and C.H. Heldin, Specific cleavage of the fibroblast receptor for platelet-derived growth factor by an endogenous Ca2+ — dependent thiol protease, Eur. J. Biochem. 155:409 (1986).
I. Kondo, and N. Schimizu, Mapping of the human gene for epidermal growth factor receptor (EGFR) on the p13-q22 region of human chromosome 7, Cytogenet. Cell Genet. 35:9 (1983).
N. Kamata, K. Chida, K. Rikimaru, M. Horikoshi, and S. Enomoto, et al., Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture, Cancer Res. 46:1648 (1986).
G.P. Cowley, J.A. Smith, and B.A. Gusterson, Increased EGF receptors on human squamous carcinoma cell lines, Br. J. Cancer 53:223 (1986).
J. Filmus, M.N. Pollak, R. Cailleau, and R.N. Buick, MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF, Biochem. Biophys. Res. Commun. 128:898 (1985).
Y. Xu, S. Ishii, A.J.L. Clark, M. Sullivan, and R. Wilson, et al., Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A4312 carcinoma cells, Nature 309:806 (1984).
Y. Xu, N. Richert, S. Ito, G.T. Merlino, and I. Pastan, Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines, Proc. Natl. Acad. Sci. USA 81:7308 (1984).
A.J.L. Clark, S. Ishii, N. Richert, G.T. Merlino, and I. Pastan, Epidermal growth factor regulates the expression of its own receptor, Proc. Natl. Acad. Sci. USA 82:8374 (1985).
H.S. Earp, K.S. Austin, J. Blaisdell, R.A. Rubin, and K.G. Nelson, et al., Epidermal growth factor (EGF) stimulates EGF receptor synthesis, J. Biol. Chem. 261:4777 (1985).
J.E. Kudlow, C.Y.M. Cheung, and J.D. Bjorge, Epidermal growth factor stimulates the synthesis of its own receptor in a human breast cancer cell line, J. Biol. Chem. 261:4134 (1986).
M.N. Krupp, D.T. Connolly, and M.D. Lane, Synthesis, turnover, and down-regulation of epidermal growth factor receptors in human A431 epidermoid carcinoma cells and skin fibroblasts, J. Biol. Chem. 257:11489 (1982).
C.M. Stoscheck, A.M. Soderquist, and G. Carpenter, Biosynthesis of the epidermal growth factor receptor in cultured human cells, Endocrinology 116:528 (1985).
C.M. Stoscheck, and G. Carpenter, Characterization of the metabolic turnover of epidermal growth factor receptor protein in A-431 cells, J. Cell Physiol. 120:296 (1984).
S.J. Decker, Effects of epidermal growth factor and 12-o-tetradacanoyl phorbol-13-acetate on metabolism of the epidermal growth factor receptor in normal human fibroblasts, Mol. Cell Biol. 4:1718 (1984).
C.R. Carlin, and B.B. Knowles, Biosynthesis of the epidermal growth factor receptor in human epidermoid carcinoma-derived A431 cells, J. Biol. Chem. 259:7902 (1984).
L.J. Slieker, and M.D. Lane, Post-translational processing of the epidermal growth factor receptor, J. Biol. Chem. 260:687 (1985).
J.P. Merlie, Biogenesis of the acetylcholine receptor, a multisubunit integral membrane protein, Cell 36:573 (1984).
G.V. Ronnett, G. Tennekoon, V.P. Knutson, and M.D. Lane, Kinetics of insulin receptor transit to and removal from the plasma membrane, J. Biol. Chem. 258:283 (1983).
R.M. Pratt, and I. Pastan, Decreased binding of epidermal growth factor to Balb/c 3T3 mutant cells defective in glycoprotein synthesis, Nature 272:68 (1978).
P.P. Breitfield, D. Rup, and A.L. Schwartz, Influence of the N-linked oligosaccharides on the biosynthesis, intracellular routing and function of the human asialoglycoprotein receptor, J. Biol. Chem. 259:10414 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this chapter
Cite this chapter
Soderquist, A.M., Todderud, G., Carpenter, G. (1988). The Role of Carbohydrate as a Post-Translational Modification of the Receptor for Epidermal Growth Factor. In: Zappia, V., Galletti, P., Porta, R., Wold, F. (eds) Advances in Post-Translational Modifications of Proteins and Aging. Advances in Experimental Medicine and Biology, vol 231. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-9042-8_48
Download citation
DOI: https://doi.org/10.1007/978-1-4684-9042-8_48
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-9044-2
Online ISBN: 978-1-4684-9042-8
eBook Packages: Springer Book Archive